- Acne
- Actinic Keratosis
- Aesthetics
- Alopecia
- Atopic Dermatitis
- Buy-and-Bill
- COVID-19
- Case-Based Roundtable
- Chronic Hand Eczema
- Drug Watch
- Eczema
- General Dermatology
- Hidradenitis Suppurativa
- Melasma
- NP and PA
- Pediatric Dermatology
- Pigmentary Disorders
- Practice Management
- Precision Medicine and Biologics
- Prurigo Nodularis
- Psoriasis
- Psoriatic Arthritis
- Rare Disease
- Rosacea
- Skin Cancer
- Vitiligo
- Wound Care
Quiz
Poll
QUIZ: Test Your Psoriasis Knowledge
Author(s):
Test your knowledge of psoriasis treatment options with our 5-question quiz.
boyhey/Adobe Stock
How much do you know about inflammation in psoriasis, biologic methods of action, treatment-emergent adverse events, topical therapies, and biosimilars?
Dermatology Times wants you to test your knowledge of psoriasis treatment options.
Take our 5-question quiz below.
Question 1: What is the hypothesized main contributor to the inflammation seen in psoriasis, according to recent research into the pathophysiology of the disease?
Related Videos
IL-17 Inhibitor Treatment Impact on Quality of Life in Psoriasis and Psoriatic Arthritis
Clinical Attributes of IL-17 Inhibitors in Psoriasis
Mechanism of Action Differences Among IL-17 Inhibitors
The Role of IL-17 in Psoriasis Pathogenesis
New Research Confirms Effective Therapy for Nail Psoriasis
New Biomarker Test Revolutionizes Inflammatory Skin Disease Diagnosis
Jeff Stark, MD: Discussing Bimzelx’s Efficacy and Future in Treating Inflammatory Skin Diseases
Addressing Disparities in Inflammatory Skin Diseases in Darker Skin Tones
Jeff Stark, MD: Reviewing UCB's Abstracts Across HS, PsO, PsA, and More
Pipeline Updates on the Horizon From Arcutis Biotherapeutics
Related Content
